The Pain Reliever and Heroin Epidemic in the United States: Shifting Winds in the Perfect Storm

Journal of Addictive Diseases

Volumn 34, Issue 2-3, 2015, Pages 127-140

  Maxwell, Jane Carlisle ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

buprenorphine; heroin; Medication assisted therapy; methadone; naltrexone; opioid epidemic; prescription pain medications

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; FENTANYL; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE; PRESCRIPTION DRUG; TRAMADOL; TRANQUILIZER; ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; DEMOGRAPHY; DRUG SUBSTITUTION; EMERGENCY WARD; EPIDEMIC; FEMALE; HEROIN DEPENDENCE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PAIN; PATIENT IDENTIFICATION; PRESCRIPTION DRUG DIVERSION; UNITED STATES; ADOLESCENT; AGED; MIDDLE AGED; OPIOID-RELATED DISORDERS; REGISTER; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALGESICS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; REGISTRIES; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84940197976     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2015.1059667     Document Type: Article

References (38)

1. Executive Office of the President of the United States. Epidemic: Responding to America's prescription drug abuse crisis. http://www. whitehouse. gov/sites/default/ files/ondcp/issues-content/prescriptiondrugs/ rx-abuse-plan-0. pdf
2. Maxwell J. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011; 30:264-70.
3. Johnston L, O'Malley PM, Bachman JG, Schulenberg JE, Miech RA. Monitoring the future national survey results on drug use: 2014 overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University of Michigan, 2015.
4. SAMHSA. Results from the 2013 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: 2014.
5. SAMHSA. Results from the 2013 National Survey on Drug Use and Health: detailed tables 1. 1a, 1. 1b, 4. 1b, 5. 2a. http:// samhsa. gov/data/NSDUH/2013SummNat FindDetTables/DetTabs/NSDUH-DetTab sTOC2013. htm
6. Watson WA, Litovitz TL, Rodgers GC, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Younis J, Flanagan A, Wruk KM. 2004 Annual report of the American Association of Poison Control Centers toxic exposure surveillance system, Am J Emerg Me 2005; 23(5): 589-66. Accessed 10/31/ 2014.
7. Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM. 2005 Annual report of the American Association of Poison Control Centers national poisoning and exposure database. Clin Tox 2006; 44 (6-7): 803-932.
8. Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Heard SE. 2006 Annual report of the American Association of Poison Control Centers national poison data system. Clin Tox 2007; 45(8): 815-917.
9. Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Heard SE. 2007 Annual report of the American Association of Poison Control Centers national poison data system. Clin Tox 2008; 4 (10):927-1057.
10. Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Giffin SL. 26th Annual report of the American Association of Poison Control Centers national poison data system (NPDS). Clin Tox 2009; 4 (10): 911-1084.
11. Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Giffin SL. 2010 Annual report of the American Association of Poison Control Centers national poison data system (NPDS). Clin Tox 2010; 4 (10): 979-1178.
12. Bronstein AC, Spyker DA, Cantilena LR, Green J, Dart RC. 2011 Annual report of the American Association of Poison Control Centers national poison data system (NPDS). Clin Tox 2011; (49): 910-941.
13. Bronstein AC, Spyker DA, Cantilena LR, Green J, Dart RC. 2011 Annual report of the American Association of Poison Control Centers national poison data system (NPDS). Clin Tox 2011; (49): 910-941.
14. Mowry JB, Spyker DA, Cantilena LR, Bailey JE, Ford MD. 2013 Annual report of the American Association of Poison Control Centers national poison data system (NPDS). Clin Tox 2013; (51): 949-1229.
15. Mowry JB, Spyker DA, Cantilena LR, McMillan N, Ford M. Clin Tox 2014; (52): 1032-1283.
16. United Nations Office on Drugs and Crime. World drug report 2014. United Nations; 2014. Vienna.
17. SAMHSA, Drug Abuse Warning Network, 2011: National estimates of drug-related emergency department visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: 2013. Available from http://www. drugabuse. gov/sites/default/ files/files/June-2013-Vol1-508. pdf. Accessed 10/31/2014.
18. NIDA. Epidemiologic trends in drug abuse: Proceedings of the community epidemiology work group, June 2013. Available from: http://www. drugabuse. gov/sites/ default/files/cewg-jan2014. Accessed 10/ 31/2014">http://www. drugabuse. gov/sites/ default/files/files/June-2013-Vol1-508. pdf http://www. drugabuse. gov/sites/default/ files/cewg-jan2014. Accessed 10/31/2014.
19. Hildegard H, Chen L-H, Warner M. Quick Stats: Rates for drug poisoning deaths involving heroin, by selected age and racial/ethnic group, United States, 2002 and 2011. CDC, MMWR, July 11, 2014; 63 (27): 595.
20. Jones CM, Campoplano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medications-assisted treatment. Am J. Public Health 2015. Available at http://ajph. aphapublications. org/doi/pdf/10. 2105/ AJPH. 2015. 302664. Accessed 7/13/2015.
21. Pollini R, Banta-Green C, Cuevas-Moat J, Metzger M, Teshale E, Garfein R. Problematic use of prescription type opioids prior to heroin use among young heroin injectors. Sub Abuse and Rehab 2011; 173-180.
22. Muhuri P, Gfroerer J, Davies M. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBMSQ data review, SAMHSA, August 2013. Available at http://www. samhsa. gov/ data/sites/default/files/DR006/DR006/non medical-pain-reliever-use-2013. htm. Accessed 7/14/2015.
23. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug and Alc Dep 2013; 132: 95-100.
24. Cicero T, Ellis M, Surratt H, Kurtz S. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. AMA Psyc 2014; 71(7):821-826.
25. Maxwell J, McCance-Katz E. Indicators of buprenorphine and methadone use and abuse: what do we know? Amer J Add 2009; 19: 73-88.
26. Schuman-Olivier Z, Hoeppner B, Weiss R, Borodovsky J, Shaffer H, Albanese J. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug and Alc Dep 2013; 132(2): 580-586.
27. Mack K, Jones C, Paulozzi L. Vital Signs: overdoses of prescription opioid pain relievers and other drugs among women- United States, 1999-2010, MMWR 2013; 62(26): 537-542.
28. Maxwell J. Epidemiology and demography of prescription drugs and older people, in Crome I., Crome P, Rao T, Wu L-T, eds, Substance Use in Older People. Oxford: Wiley Press, 2014.
29. Jones CM, Lurie P, Woodcock J. Addressing prescription opioid overdose: Data support a comprehensive policy approach. JAMA 2014; 312 (17): 1733-1734.
30. Severtson S, Bartelson B, Davis J, Muno A, Schneider M, Chilcoat H, Coplan P, Suratt H, Dart R. Reduced abuse, therapeutic errors and diversion following reformulation of extended-release oxycodone in 2010. J Pain 2013; 14 (10):1122-1130.
31. Butler S, Cassidy T, Chilcoat H, Black R, Landau C, Budman S, Coplan P. Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain 2013; 14(4): 351-358.
32. Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B. Decline in drug overdose deaths after state policy changes-Florida, 2010-2012, MMWR; 2013; 63(26): 569-574.
33. PDMP Center of Excellence, Brandeis University, Briefing on PDMP Effectiveness, Update September 2014. http:// www. pdmpexcellence. org/sites/all/pdfs/ Briefing%20on%20PDMP%20Effective ness%203rd%20revision. pdf. Accessed 10/13/2014.
34. Kreiner P, Nikitin R, Shields T. Bureau of Justice Assistance Prescription Drug Monitoring Program Performance Measures Report: January 2009 through June 2012; Revised October 21, 2013-Grantee feedback included April 4, 2014 The Prescription Drug Monitoring Program Center of Excellence Heller School for Social Policy and Management, Brandeis University. Available from http://www. pdmpexcel lence. org/sites/all/pdfs/BJA%20PDMP% 20Performance%20Measures%20Report% 20Jan%202009%20to%20June%202012% 20FInal-with%20feedback. pdf. Accessed 10/13/2014.
35. Institute of Medicine, Treating Drug Problems, Vol. 1, Gerstein D, Harwood H, eds. National Academy Press, Washington DC 1990.
36. Capelhorn J. Knowledge of methadone toxicity among US maintenance clinic staff. J. Maint Addict 2000; 1(4) 63-72.
37. Capelhorn J, Dalton S, Halda F, Petrenas AM, Nisbet J. Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse 1996; 3: 177-196.
38. Zador D, Sunjic S. 2002. Methadonerelated deaths and mortality rate during induction into methadone maintenance, New South Wales, 1996. Drug Alcohol Rev; 21: 131-136.